Zhejiang University: clinical-trial pipeline
Zhejiang University is the sponsor of 352 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 133 are not yet finished and 3 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 152 |
| Phase 2 | 60 |
| Early phase 1 | 54 |
| Phase 1 | 45 |
| Phase 1/2 | 15 |
| Phase 3 | 14 |
| Phase 4 | 10 |
| Phase 2/3 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 110 |
| Completed | 94 |
| Recruiting | 72 |
| Not yet recruiting | 54 |
| Withdrawn or not authorised | 8 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Suspended or halted | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 208 |
| Gastroenterology and liver | 104 |
| Immunology and rheumatology | 33 |
| Cardiovascular | 29 |
| Metabolic and endocrine (diabetes, obesity) | 21 |
| Infectious disease and vaccines | 13 |
| Nephrology and urology | 13 |
| Haematology | 12 |
| Respiratory | 12 |
| Neurology | 11 |
| Rare and genetic diseases | 7 |
| Women's health and obstetrics | 7 |
Countries
| Country | Trials |
|---|---|
| China | 304 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-10 | New trial posted | Physician and Patient Preferences for Cell Therapies in Advanced Solid Tumors |
| 2026-08-28 | New trial posted | High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients… |
| 2026-08-27 | New trial posted | A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuxi… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05155189 | A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular C… | Phase 1 | Recruiting | China |
| NCT07240857 | A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T… | Early phase 1 | Recruiting | China |
| NCT07729917 | Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study | Phase 2 | Not yet recruiting | China |
| NCT05593458 | Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric C… | Phase 3 | Recruiting | China |
| NCT06920446 | UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia | Early phase 1 | Not yet recruiting | |
| NCT04661020 | CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma | Phase 2 | Recruiting | China |
| NCT04657965 | LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies | Early phase 1 | Not yet recruiting | China |
| NCT07080697 | A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral P… | Not applicable | Recruiting | China |
| NCT07199855 | Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B… | Phase 2 | Active, not recruiting | China |
| NCT06633328 | CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia | Early phase 1 | Recruiting | China |
| NCT07049094 | The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Cra… | Phase 4 | Recruiting | China |
| NCT06188273 | Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation | Not applicable | Not yet recruiting | |
| NCT04657861 | APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma | Early phase 1 | Recruiting | China |
| NCT07474168 | T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations… | Phase 1 | Active, not recruiting | China |
| NCT07415525 | IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer | Phase 2 | Not yet recruiting | China |
| NCT07767916 | AI-Assisted Feedback for Learning Standardized Tuina Skills | Not applicable | Not yet recruiting | |
| NCT07766668 | Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia | Not applicable | Not yet recruiting | China |
| NCT06796764 | COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patie… | Not applicable | Recruiting | China |
| NCT03813706 | the Dissection of Lymph Node Posterior to Right Recurrent Laryngeal Nerve for Papillary Thyroid Carcinoma | Not applicable | Not yet recruiting | |
| NCT04603872 | CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Maligna… | Early phase 1 | Recruiting | China |
| NCT05731726 | Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer | Phase 2 | Recruiting | China |
| NCT06220617 | Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC) | Not applicable | Recruiting | China |
| NCT07779694 | 16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Can… | Phase 2 | Not yet recruiting | |
| NCT07257640 | IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia | Phase 1 | Recruiting | China |
| NCT05923255 | LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Zhejiang University clinical trials: 133 open, 16 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/zhejiang-university/, data as of 2026-10-25.